In the wake of a startling deal in which Allergan (AGN) is selling some patents to a Native American tribe, an attorney for the tribe indicated other drug makers have asked about such arrangements.
“I can’t provide specific information, but your assumptions are pretty correct” that representatives for other pharmaceutical companies have made inquiries since the deal was announced last Friday, said Chris Evans of the Shore Chan DePumpo law firm, which brought the deal to the tribe.
About the Author Reprints
